| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $2.74B | -1.2% |
| Cost of Revenue | $1.70B | -3.2% |
| Gross Profit | $1.04B | +2.1% |
| R&D Expense | $39.2M | +1.0% |
| SG&A Expense | $579.8M | -1.3% |
| Operating Income | $447.4M | +10.7% |
| Pre-tax Income | $370.4M | +16.1% |
| Income Tax | $77.3M | -19.2% |
| Net Income | $264.8M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $249.4M | +144.5% |
| Accounts Receivable | $370.3M | -3.9% |
| Inventory | $403.7M | +2.8% |
| Current Assets | $1.15B | +15.1% |
| Total Assets | $4.03B | +5.4% |
| Current Liabilities | $632.1M | +1.9% |
| Long-term Debt | $1.06B | +4.2% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $355.4M | +7.5% |
| Capital Expenditures | $51.8M | +7.5% |
| Investing Cash Flow | -$205.7M | -230.5% |
| Financing Cash Flow | $31.7M | +114.4% |
| Free Cash Flow | $303.6M | +7.5% |
| +29.0% |
| EPS (Basic) | $4.36 | +28.6% |
| EPS (Diluted) | $4.31 | +28.3% |
| Total Liabilities |
| $2.23B |
| +2.1% |
| Stockholders' Equity | $1.77B | +10.1% |